SR

Srinivasa Rao Nimmagadda

Director Director DIN 07308211
DIN 07308211 First appointment Feb 2016 Primary industry Chemicals and Materials
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Feb 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Srinivasa Rao Nimmagadda

Data last updated:

Srinivasa Rao Nimmagadda was a Director at Natural Right Medicines India Private Limited (2016–2019). The company operates in Chemicals and Materials.

DIN 07308211
Primary Designation Director
Industry Chemicals and Materials
First Appointment 08 Feb 2016

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director08 Feb 20162016Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Natural Right Medicines India Private Limited
Premium access

Shareholding and investment profile for Srinivasa Rao Nimmagadda

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Srinivasa Rao Nimmagadda

Srinivasa Rao Nimmagadda was first appointed on 08 Feb 2016 as Director at Natural Right Medicines India Private Limited.

Srinivasa Rao Nimmagadda held 1 earlier board appointment: Natural Right Medicines India Private Limited (Director, 08 Feb 2016 to 04 Dec 2019).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available